Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 34, 2004 - Issue 6
32
Views
1
CrossRef citations to date
0
Altmetric
Research Article

In vitro assessment of intestinal permeability and hepatic metabolism of 4′-bromoflavone, a promising cancer chemopreventive agent

, , , , , , & show all
Pages 535-547 | Received 22 Jan 2004, Published online: 22 Sep 2008

Reference

  • ADAMS, C. J. and MAIN, L., 1991, Synthesis of 2'-hydroxychalcone epoxides. Tetrahedron, 47, 4959–4978.
  • ARTURSSON, P., PALM, K. and LUTHMAN, K., 2001, Caco-2 monolayers in experimental and theoretical predictions of drug transport. Advanced Drug Delivery Reviews, 46, 27–43.
  • EKINS, S., RING, B. J., GRACE, J., MCROBIE-BELLE, D. J. and WRIGHTON, S. A., 2000, Present and future in vitro approaches for drug metabolism. Journal of Pharmacological and Toxicological Methods, 44, 313–324.
  • GERHAUSER, C., You, M., Liu, J., MORIARTY, R. M., HAWTHORNE, M., MEHTA, R. G., MOON, R. C. and PEZZUTO, J. M., 1997, Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Research, 57, 272–278.
  • GRES, M. C., JULIAN, B., BOURRIE, M., MEUNIER, V., ROQUES, C., BERGER, M., BOULENC, X., BERGER, Y. and FABRE, G., 1998, Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharmaceutical Research, 15, 726–733.
  • HIDALGO, I. J., RAUB, T. J. and BORCHARDT, R. T., 1989, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736–749.
  • HONG, W. K. and SPORN, M. B., 1997, Recent advances in chemoprevention of cancer. Science, 278, 1073–1077.
  • HUNTER, J., JEPSON, M. A., TSURUO, T., SIMMONS, N. L. and HIRST, B. H., 1993, Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. Journal of Biological Chemistry, 268, 14991–14997.
  • KUCUK, 0., 2002, Cancer chemoprevention. Cancer and Metastasis Reviews, 21, 189–197.
  • LI, A. P., 2001, Screening for human ADME/Tox drug properties in drug discovery. Drug Discovery Today, 6, 357–366.
  • LI, C., CHAURET, N., TRIMBLE, L. A., NICOLL-GRIFFITH, D. A., SILVA, J. M., MACDONALD, D., PERRIER, H., YERGEY, J. A., PARTON, T., ALEXANDER, R. P. and WARRELLOW, G. J., 2001, Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization. Drug Metabolism and Disposition, 29, 232–241.
  • LI, Y., SHIN, Y. G., Yu, C., KOSMEDER, J. W., HIRSCHELMAN, W. H., PEZZUTO, J. M. and VAN BREEMEN, R. B., 2003, Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism. Combinatorial Chemistry and High Throughput Screening, 6, 757–767.
  • LIN, J. H. and Lu, A. Y., 1997, Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacological Reviews, 49, 403–449.
  • MA, Y. L., LI, Q. M., VAN DEN HEUVEL, H. and CLAEYS, M., 1997, Characterization of fiavone and fiavonol aglycons by collision-induced dissociation tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 11, 1357–1364.
  • MEHTA, R. G., Liu, J., CONSTANTINOU, A., THOMAS, C. F., HAWTHORNE, M., You, M., GERHUSER, C., PEZZUTO, J. M., MOON, R. C. and MORIARTY, R. M., 1995, Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis, 16, 399–404.
  • MEHTA, R. G. and PEZZUTO, J. M., 2002, Discovery of cancer preventive agents from natural products: from plants to prevention. Current Oncology Reports, 4, 478–486.
  • NIESSEN, W. M., 2003, Progress in liquid chromatography-mass spectrometry instrumentation and its impact on high-throughput screening. Journal of Chromatography A, 1000, 413–436.
  • OTAKE, Y., HSIEH, F. and WALLE, T., 2002, Glucuronidation versus oxidation of the fiavonoid galangin by human liver microsomes and hepatocytes. Drug Metabolism and Disposition, 30, 576–581.
  • POON, G. K., KWEI, G., WANG, R., LYONS, K., CHEN, Q., DIDOLKAR, V. and HOP, C. E., 1999, Integrating qualitative and quantitative liquid chromatography/tandem mass spectrometric analysis to support drug discovery. Rapid Communications in Mass Spectrometry, 13, 1943–1950.
  • SONG, L. L., KOSMEDER, J. W., 2ND, LEE, S. K., GERHAUSER, C., LANTVIT, D., MOON, R. C., MORIARTY, R. M. and PEZZUTO, J. M., 1999, Cancer chemopreventive activity mediated by 4'-bromofiavone, a potent inducer of phase II detoxification enzymes. Cancer Research, 59, 578–585.
  • TALALAY, P., FAHEY, J. W., HOLTZCLAW, W. D., PRESTERA, T. and ZHANG, Y., 1995, Chemoprotection against cancer by phase 2 enzyme induction. Toxicology Letters, 82–83, 173–179.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.